All stock lists
Concentrix Corp (NASDAQ:CNXC)
US · Delayed Price · Currency is USD
Technology · Information Technology Services
30.34-0.19 (-0.62%)
Market cap
$1.85B
Insider Score
Health Score
Analyst consensus
Listed since
Nov 24, 2020
Website
Insider Score
––Not scored
CNXC Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
CNXC analyst forecast
CNXC analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
CNXC 12-month price target
No published price targets in the last 12 months.
CNXC ratings mix, last 12 months
Buy Hold Sell
Best analysts covering CNXC
- Barrington Research5%success rate · -31.3% avg return · 19 calls
- Canaccord Genuity0%success rate · -30.6% avg return · 7 calls
- Baird0%success rate · -49.1% avg return · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CNXC analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-09-30 |
| — | Baird | Outperform | — | — | Reiterated | 2026-06-30 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-06-30 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-06-30 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2026-06-30 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2026-06-22 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2026-03-25 |
| — | Baird | Outperform | — | — | Reiterated | 2026-03-25 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-03-25 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2026-03-17 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2026-01-12 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-11-20 |
| — | Baird | Outperform | — | — | Reiterated | 2025-09-29 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-09-26 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-09-26 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-09-24 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-09-23 |
| — | Baird | Outperform | — | — | Reiterated | 2025-09-18 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-06-30 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-06-27 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2025-06-27 |
| — | Baird | Outperform | — | — | Reiterated | 2025-06-26 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-06-24 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2025-06-09 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-03-27 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2025-03-27 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-03-24 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-01-16 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2024-09-26 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2024-09-26 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-09-26 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2024-09-23 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2024-09-20 |
| — | B of A Securities | Neutral | — | — | Upgraded | 2024-08-28 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-06-27 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2024-06-21 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2024-04-29 |
| — | B of A Securities | Underperform | — | — | Downgraded | 2024-03-27 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2024-03-27 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2024-03-20 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2024-01-25 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2023-06-29 |
| — | B of A Securities | Neutral | — | — | Downgraded | 2023-06-29 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2023-06-26 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2023-04-12 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2023-03-30 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2023-03-27 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2022-09-30 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2022-07-05 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2021-06-15 |
| — | Cross Research | Buy | — | — | Reiterated | 2021-01-08 |
| — | B of A Securities | Buy | — | — | Reiterated | 2020-12-07 |
| — | Citigroup | Neutral | — | — | Reiterated | 2017-10-16 |
| — | Jefferies | Buy | — | — | Upgraded | 2016-11-09 |
| — | Jefferies | Hold | — | — | Reiterated | 2016-10-04 |
| — | Jefferies | Hold | — | — | Reiterated | 2016-09-19 |
| — | Jefferies | Hold | — | — | Reiterated | 2016-08-22 |
| — | Stifel | Buy | — | — | Reiterated | 2016-07-27 |
CNXC earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-01-13 | 2.91 | 2.95 | $2.54B | $2.55B |
| 2026-03-24 | 2.64 | 2.61 | $2.49B | $2.50B |
| 2026-06-29 | 2.64 | 2.63 | $2.47B | $2.46B |
| 2026-09-29 | 2.71 | 2.92 | $2.48B | $2.45B |
| 2027-01-12Upcoming | 2.92 | — | $2.44B | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.